Nowak C, Arnold W, Henneberger G, Tanneberger S
Arch Geschwulstforsch. 1983;53(1):45-52.
Additive an synergistic therapeutic effects are demonstrable in the murine L 1210 model following combined application of CRM with CTX. Cytostasane, 5-FU, DTIC and CCNU, while combinations of CRM with L-PAM, BLM, DBD, CLB or MTX gave no such effects.
在将CRM与CTX联合应用于小鼠L 1210模型后,可证明其具有相加和协同治疗效果。细胞生长抑制剂、5-氟尿嘧啶、氮烯咪胺和环己亚硝脲有此效果,而CRM与左旋苯丙氨酸氮芥、博来霉素、二溴卫矛醇、苯丁酸氮芥或甲氨蝶呤联合使用则无此效果。